LHC Group, Inc. (NASDAQ:LHCG) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,457,339 shares, a growth of 41.0% from the November 15th total of 1,033,447 shares. Based on an average daily volume of 331,051 shares, the short-interest ratio is currently 4.4 days. Approximately 8.9% of the company’s shares are short sold.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Federated Investors Inc. PA increased its holdings in LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after purchasing an additional 66 shares during the period. Acrospire Investment Management LLC increased its holdings in LHC Group by 30.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $115,000 after purchasing an additional 400 shares during the period. Cubist Systematic Strategies LLC increased its holdings in LHC Group by 758.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock worth $116,000 after purchasing an additional 1,516 shares during the period. First Mercantile Trust Co. purchased a new position in LHC Group during the 2nd quarter worth $147,000. Finally, SG Americas Securities LLC purchased a new position in LHC Group during the 3rd quarter worth $163,000. Institutional investors own 85.51% of the company’s stock.

Several research firms have recently issued reports on LHCG. SunTrust Banks reaffirmed a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a research note on Friday, November 3rd. Zacks Investment Research lowered LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Oppenheimer raised their price objective on LHC Group from $68.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th. Craig Hallum reaffirmed a “buy” rating and issued a $80.00 price objective (up from $67.00) on shares of LHC Group in a research note on Tuesday, November 7th. Finally, Royal Bank of Canada raised their price objective on LHC Group from $70.00 to $81.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $77.10.

LHC Group (LHCG) opened at $60.48 on Friday. The company has a market capitalization of $1,110.00, a price-to-earnings ratio of 26.44, a price-to-earnings-growth ratio of 1.83 and a beta of 0.69. LHC Group has a fifty-two week low of $42.90 and a fifty-two week high of $76.14. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, topping the consensus estimate of $0.60 by $0.04. The company had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. LHC Group had a return on equity of 9.52% and a net margin of 4.09%. LHC Group’s quarterly revenue was up 18.2% on a year-over-year basis. During the same period last year, the business posted $0.54 EPS. equities analysts predict that LHC Group will post 2.4 earnings per share for the current fiscal year.

WARNING: This story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/15/short-interest-in-lhc-group-inc-lhcg-rises-by-41-0.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.